FindTrial
Sign In

effectiveness of lecithinum medicine in management of anemia

effectiveness of lecithinum in management of anemia an uncontrolled experimental study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051936
Enrollment
60
Registered
2023-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D649- Anemia, unspecified

Interventions

Intervention1: Lecithinum Q: Lecithinum Mother Tincture to be given Orally in form of drops. Twice daily in morning and evening. 10 drops each time for 3 months after which investigation will be advis

Sponsors

Riya Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically established cases of Anamemia with Haemoglobin >5gm/dL and <10.5gm/dL

Exclusion criteria

Exclusion criteria: Pregnant Women. Patient with Haemoglobin Megaloblastic, Aplastic, Hemolytic Anaemia Certain inherited type of Anaemia including Thalassemia Major, Sickle cell, Pernicious Anaemia can be life threatening

Design outcomes

Primary

MeasureTime frame
changes in Haemoglobin parameter(gm/dL) after administration of Lecithinum Q in cases of AnaemiaTimepoint: 12 months—

Secondary

MeasureTime frame
to find out clinical symptoms of LecithinumTimepoint: 12 months—

Countries

India

Contacts

Public ContactRiya Gupta

Swasthya Kalyan Homoeopathic medical college and Research Centre

homeopathy@swasthyakalyan.org9414229555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026